Choose an Ailment
Alcoholism ALS Alzheimer’s Disease Anorexia Anxiety Disorders Arthritis Asthma Autism Back Pain Bladder Cancer Brain Cancer Breast Cancer Cerebral Palsy Chronic Pain Chronic Stress Colon Cancer COPD
Crohn's Disease Depression Diabetes Disc Degeneration Epilepsy & Seizures Fibromyalgia Glaucoma Heart Disease HIV / AIDS Huntington’s Disease Leukemia Liver Disease Lung Cancer Lupus Malaria Migraines Multiple Sclerosis
Latest Ailment Research
Cannabinoids May Fight Pancreatic Cancer Growth
A 2006 spanish study suggests that cannabinoids could provide a new therapeutic approach for the treatment of pancreatic cancer.
Cannabinoid Therapies for the Treatment of Alcoholism
Studies show cannabinoid therapies aimed at increasing signaling of cannabinoid receptors in the brains of alcohol-dependent individuals may be useful
Dr. Sean Breen Discusses Medical Marijuana and Lupus
Medical director Dr. Sean Breen of Medical Cannabis of Southern California discusses that success of a patient using cannabis to treat lupus.
Cannabis May Decrease Pain From Multiple Sclerosis
A clinical study lead by the University of California showed reduction in pain from Multiple Sclerosis (MS) in patients who smoked medical marijuana.
Cannabinoids May Help Relieve Migraines
The Headache Group conducted a study to determine the impact of the CB1 receptor in migraines.
Teen Treats Acute Lymphoblastic Leukemia With Cannabis
A 14-year-old patient from Canada turned to medical marijuana when traditional methods were unsuccessful in treating the leukemia.
Endocannabinoids in the Treatment of Prostate Cancer
An in-vitro study published in Oncology Reports in January 2015 found that stimulation of cannabinoid receptors helped treat prostate cancer symptoms.
Cannabidiol (CBD) in the Treatment of Cerebral Malaria
A January 2015 study in Neuroscience found that cannabidiol (CBD) increased survival & improved mental functioning in mice with cerebral malaria.
CBD May Reduce Obsessive-Compulsive Activity
A recent study shows that low doses of cannabidiol (CBD) could have an anti-compulsive effect in subjects without increasing overall activity.